Mps1-IN-8, with the CAS number 2259843-95-1, is a small molecule inhibitor that targets the Mps1 kinase, an essential regulator of the spindle assembly checkpoint in cell division. This compound is characterized by its ability to interfere with the function of Mps1, thereby affecting the proper segregation of chromosomes during mitosis. Mps1-IN-8 has been studied for its potential applications in cancer therapy, particularly in tumors that exhibit aberrant cell division and checkpoint dysregulation. The compound typically exhibits moderate to high potency against Mps1, and its structure includes specific functional groups that facilitate binding to the kinase's active site. Additionally, Mps1-IN-8 may demonstrate favorable pharmacokinetic properties, such as solubility and bioavailability, which are crucial for its efficacy in therapeutic settings. Research into Mps1 inhibitors like Mps1-IN-8 continues to explore their role in enhancing the effectiveness of existing cancer treatments and overcoming resistance mechanisms in various cancer types.

Mps1-IN-8

2259843-95-1: Mps1-IN-8, with the CAS number 2259843-95-1, is a small molecule inhibitor that targets the Mps1 kinase, an essential regulator of the spindle assembly checkpoint in cell division. This compound is characterized by its ability to interfere with the function of Mps1, thereby affecting the proper segregation of chromosomes during mitosis. Mps1-IN-8 has been studied for its potential applications in cancer therapy, particularly in tumors that exhibit aberrant cell division and checkpoint dysregulation. The compound typically exhibits moderate to high potency against Mps1, and its structure includes specific functional groups that facilitate binding to the kinase's active site. Additionally, Mps1-IN-8 may demonstrate favorable pharmacokinetic properties, such as solubility and bioavailability, which are crucial for its efficacy in therapeutic settings. Research into Mps1 inhibitors like Mps1-IN-8 continues to explore their role in enhancing the effectiveness of existing cancer treatments and overcoming resistance mechanisms in various cancer types.

Mps1-IN-8, a Mps1 inhibitor, can be utilized in the study of various tumors [1].

CAS 2259843-95-1

Mps1-IN-8

Mps1-IN-8

Ref: TM-T86927